Bloomage Biotechnology Corp Ltd (688363)

Currency in CNY
51.95
+0.13(+0.25%)
Closed·
688363 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688363 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51.5352.58
52 wk Range
42.5184.59
Key Statistics
Bid/Ask
51.94 / 51.95
Prev. Close
51.82
Open
52.09
Day's Range
51.53-52.58
52 wk Range
42.51-84.59
Volume
3.01M
Average Volume (3m)
3.74M
1-Year Change
-16.01%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688363 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
48.03
Downside
-7.56%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Bloomage Biotechnology Corp Ltd Company Profile

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People’s Republic of China.

Employees
4444
Market
China

Compare 688363 to Peers and Sector

Metrics to compare
688363
Peers
Sector
Relationship
P/E Ratio
757.8x31.8x12.1x
PEG Ratio
−7.99−0.660.03
Price/Book
3.6x2.6x1.5x
Price / LTM Sales
4.9x3.2x0.9x
Upside (Analyst Target)
0.9%11.7%17.9%
Fair Value Upside
Unlock14.2%11.2%Unlock

Analyst Ratings

6 Buy
2 Hold
3 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 48.03
(-7.56% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.07%
Dividend Yield
0.21%
Industry Median 1.51%
Annualised payout
0.11
Paid annually
5-Years Growth
-21.54%
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.21 / 0.63
Revenue / Forecast
1.08B / 1.50B
EPS Revisions
Last 90 days

688363 Income Statement

FAQ

What Stock Exchange Does Bloomage Bio Trade On?

Bloomage Bio is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Bloomage Bio?

The stock symbol for Bloomage Bio is "688363."

What Is the Bloomage Bio Market Cap?

As of today, Bloomage Bio market cap is 24.85B.

What Is Bloomage Bio's Earnings Per Share (TTM)?

The Bloomage Bio EPS (TTM) is 0.07.

When Is the Next Bloomage Bio Earnings Date?

Bloomage Bio will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is 688363 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Bloomage Bio Stock Split?

Bloomage Bio has split 0 times.

How Many Employees Does Bloomage Bio Have?

Bloomage Bio has 4444 employees.

What is the current trading status of Bloomage Bio (688363)?

As of 03 Aug 2025, Bloomage Bio (688363) is trading at a price of 51.95, with a previous close of 51.82. The stock has fluctuated within a day range of 51.53 to 52.58, while its 52-week range spans from 42.51 to 84.59.

What Is Bloomage Bio (688363) Price Target According to Analysts?

The average 12-month price target for Bloomage Bio is CNY48.025, with a high estimate of CNY65 and a low estimate of CNY32. 6 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Buy. The stock has an -7.56% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.